View source for 2g69

[[Image:2g69.gif|left|200px]]

<!--
The line below this paragraph, containing "STRUCTURE_2g69", creates the "Structure Box" on the page.
You may change the PDB parameter (which sets the PDB file loaded into the applet) 
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
or leave the SCENE parameter empty for the default display.
-->
{{STRUCTURE_2g69|  PDB=2g69  |  SCENE=  }} 

'''Structure of Unliganded HIV-1 Protease F53L Mutant'''


==Overview==
Mutations in HIV-1 protease (PR) that produce resistance to antiviral PR inhibitors are a major problem in AIDS therapy. The mutation F53L arising from antiretroviral therapy was introduced into the flexible flap region of the wild-type PR to study its effect and potential role in developing drug resistance. Compared to wild-type PR, PR(F53L) showed lower (15%) catalytic efficiency, 20-fold weaker inhibition by the clinical drug indinavir, and reduced dimer stability, while the inhibition constants of two peptide analog inhibitors were slightly lower than those for PR. The crystal structure of PR(F53L) was determined in the unliganded form at 1.35 Angstrom resolution in space group P4(1)2(1)2. The tips of the flaps in PR(F53L) had a wider separation than in unliganded wild-type PR, probably due to the absence of hydrophobic interactions of the side-chains of Phe53 and Ile50'. The changes in interactions between the flaps agreed with the reduced stability of PR(F53L) relative to wild-type PR. The altered flap interactions in the unliganded form of PR(F53L) suggest a distinct mechanism for drug resistance, which has not been observed in other common drug-resistant mutants.

==About this Structure==
2G69 is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2G69 OCA]. 

==Reference==
Mechanism of drug resistance revealed by the crystal structure of the unliganded HIV-1 protease with F53L mutation., Liu F, Kovalevsky AY, Louis JM, Boross PI, Wang YF, Harrison RW, Weber IT, J Mol Biol. 2006 May 19;358(5):1191-9. Epub 2006 Mar 20. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/16569415 16569415]
[[Category: HIV-1 retropepsin]]
[[Category: Human immunodeficiency virus 1]]
[[Category: Single protein]]
[[Category: Kovalevsky, A Y.]]
[[Category: Liu, F.]]
[[Category: Aspartic protease]]
[[Category: Catalysis]]
[[Category: Flap mutant]]
[[Category: Non-active site mutant]]
[[Category: Unliganded]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May  4 04:44:05 2008''